Detection of TP53 mutations in tissue or liquid rebiopsies at progression identifies ALK+ lung cancer patients with poor survival - Christopoulos, Petros; Dietz, Steffen; Kirchner, Martina; Volckmar, Anna-Lena; Endris, Volker; Neumann, Olaf; Heußel, Claus Peter; Herth, Felix; Eichhorn, Martin E.; Meister, Michael; Budczies, Jan; Allgäuer, Michael; et al. (Cancers, 2019)
Gesehen am 26.06.2019